Literature DB >> 497095

Heparin administration increases plasma warfarin binding in man.

P A Routledge, T D Bjornsson, B B Kitchell, D G Shand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497095      PMCID: PMC1429800          DOI: 10.1111/j.1365-2125.1979.tb01016.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  A rapid gas chromatographic method for the quantitation of underivatised individual free fatty acids in plasma.

Authors:  D Sampson; W J Hensley
Journal:  Clin Chim Acta       Date:  1975-05-15       Impact factor: 3.786

2.  Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.

Authors:  M Wood; D G Shand; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

3.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

4.  Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.

Authors:  O G Nilsen; L Storstein; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1977-02-01       Impact factor: 5.858

5.  Blood collection techniques, heparin and quinidine protein binding.

Authors:  K M Kessler; R C Leech; J F Spann
Journal:  Clin Pharmacol Ther       Date:  1979-02       Impact factor: 6.875

6.  Studies on digitalis. VI. The effect of heparin on serum protein binding of digitoxin and digoxin.

Authors:  L Storstein; H Janssen
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

  6 in total
  3 in total

Review 1.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

2.  Unaltered serum propranolol binding by meal-induced variations in fatty acids.

Authors:  C A Naranjo; E M Sellers; V Khouw
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

3.  Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.

Authors:  A Johnston; J A Henry; S J Warrington; N A Hamer
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.